5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational analysis of therapy-related MDS/AML
    Meeting Abstract

    Shih, A. H.; Chung, S. S.; Dolezal, E. K.; Zhang, S. J.; Abdel-Wahab, O.; Park, C. Y.; Nimer, S. D.; Levine, R. L.; Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Dynamics of mutant alleles in patients with advanced essential thrombocythernia (ET) or polycythemia (PV) during pegylated interferon-alfa-2A (PEG-IFN-alpha-2A; pegasys) therapy
    Meeting Abstract

    Quintas-Cardama, A.; Abdel-Wahab, O.; Levine, R. L.; Manshouri, T.; Roupie, A. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • 2-Hydroxyglutarate in IDH mutant AML: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
    Meeting Abstract

    Pollyea, D. A.; Kohrt, H. E.; Zhang, B.; Zehnder, J. L.; Schenkein, D. P.; Fantin, V.; Straley, K.; Vasanthakumar, A.; Abdel-Wahab, O.; Levine, R. L.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • FTY720 restores PP2A tumor suppressor activity in polycythemia vera CD34(+) progenitors through inhibition of jak2 V617F-and PI-3K gamma-dependent SET serine phosphorylation and enhancement of NOS-dependent PP2A tyrosine nitration
    Meeting Abstract

    Oaks, J. J.; Mukhopadhyay, A.; Santhanam, R.; Saddoughi, S. A.; Neviani, P.; Harb, J. G.; Ogretmen, B.; Bittman, R.; Levine, R. L.; Quintas-Cardama, A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Evaluating clonal dominance in a murine knock-in model of jak2V617F MPN
    Meeting Abstract

    Mullally, A.; Poveromo, L.; Brumme, K.; Al-Shahrour, F.; Lane, S. W.; Shih, A. H.; Aifantis, I.; Levine, R. L.; Ebert, B. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Epigenetic effects of IDH1/IDH2 mutations
    Meeting Abstract

    Melnick, A. M.; Levine, R. L.; Figueroa, M. E.; Thompson, C. B.; Abdel-Wahab, O.
    Blood (2011)

    Fulltext@MSK | Save
  • Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome
    Meeting Abstract

    Manshouri, T.; Estrov, Z.; Knez, L.; Zhang, Y.; Levine, R. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Monocytic CCR2+myeloid derived suppressor cells promote immune escape by limiting activated CD8 T cell infiltration into the tumor microenvironment
    Meeting Abstract

    Lesokhin, A.; Hohl, T.; Merghoub, T.; Hirschhorn-Cymerman, D.; Pamer, E. G.; Houghton, A. N.; Wolchok, J. D.
    Blood (2011)

    Fulltext@MSK | Save
  • Inhibition of AKT signaling potently inhibits the growth of JAK and MPL-mutant cells in the myeloproliferative neoplasms in vitro and in vivo
    Meeting Abstract

    Khan, I.; Huang, Z.; Wen, Q. J.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save